Deadline- 28 January 2014
10th Call for proposals on “Immunological assay standardisation and development for use in assessments of correlates of protection for influenza vaccines” has been announced by Innovative Medicines Initiative (IMI). This program offers opportunity to participate in ambitious public-private partnerships that will pave the way for the development of the medicines of the future.
Why apply?
- Take part in patient-centric biomedical/pharmaceutical research
- Join unique consortia involving top teams from industry, academia, SMEs, regulators, and others
- Obtain research funding
- Gain access to the databases, knowledge and infrastructures of consortium partners
- Boost the visibility and status of their organisation in Europe and globally and gain access to new markets
Eligibility & Criteria-
- IMI’s Calls for proposals offer researchers across Europe a unique opportunity to participate in ground-breaking projects that aim to deliver tangible benefits for patients.
- IMI warmly encourages small and medium-sized enterprises (SMEs), patients’ organisations, regulatory authorities, academic teams, industry, hospitals and other organisations to form consortia and apply for participation in the new IMI projects.
For more information, visit this link
